EUVIMEDEUVIMED entdecken
Crossref

Incidence, characteristics, and risk factors of drug-associated muscle adverse reaction: a retrospective real-world study of inpatients

Anqi Zhao, Daihong Guo, Man Zhu, Ao Gao, Peng Li, An Fu

European Journal of Clinical Pharmacology · 2024

DOI: 10.1007/s00228-024-03662-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical Pharmacology, 2024. Verfasst von Anqi Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Chinese PLA Medical School, Beijing, China. Hauptthemen laut MEDLINE: Creatine Kinase, Rhabdomyolysis, Inpatients, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Key Project of Medical Innovation Project in 2017, the Project of Monitoring and Evaluation of the Use of Key Clinical Drugs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To analyze the clinical characteristics, incidence, and distribution of drug-associated muscle adverse reactions (DAMAR) in real-world inpatients, to provide valuable references for clinical medication use. METHODS: We conducted an automatic retrospective monitoring of inpatients from May 1, 2022, to April 30, 2023, to collect information on adverse drug reactions (ADR) of patients and conducted subsequent analyses. RESULTS: Among 102,430 hospitalizations, 1106 cases of DAMARs were identified, yielding an incidence of 1.08%, including 125 cases of rhabdomyolysis at an incidence of 0.12%. Seventy-five percent of the patients experienced muscle adverse reactions within 5 days after taking medication, with a median elevated creatine kinase (CK) value of 420.4 IU/L. Risk factors of DAMAR include age ≥ 65, male sex, obesity, hypertension, hepatic and renal insufficiency, and anemia. No significant correlation was observed between the duration of surgery and CK elevation, while the surgical procedure itself had an impact. The 114 drugs associated were predominantly nervous system drugs, anti-infectives for systemic use, and cardiovascular system drugs, with levofloxacin, pregabalin, and parecoxib being the most frequently associated drugs. CONCLUSION: Healthcare professionals should be vigilant with patients exhibiting the identified risk factors. Monitoring creatine kinase and related indices when using myotoxic drugs is crucial to preventing serious adverse reactions, ultimately preserving patients' quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Creatine KinaseRhabdomyolysisInpatientsDrug-Related Side Effects and Adverse ReactionsHumansMaleFemaleRisk FactorsMiddle AgedRetrospective StudiesAgedIncidenceAdultAdolescentAged, 80 and overYoung AdultHospitalizationChildMuscular Diseases

Stichwörter der Autor:innen

Automatic monitoringMuscle adverse drug reactionReal-world studyRisk factors

Substanzen

Creatine Kinase

Autor:innen und Institutionen

  • Chinese PLA Medical School, Beijing, China.
  • Department of Pharmacy, Medical Supplies Center, Chinese PLA General Hospital, Beijing, China.
  • Department of Pharmacy, Medical Supplies Center, Chinese PLA General Hospital, Beijing, China. guodh301@126.com.

Förderung

  • Key Project of Medical Innovation Project in 2017
  • the Project of Monitoring and Evaluation of the Use of Key Clinical Drugs

Zitieren

APA

Zhao, A., Guo, D., Zhu, M., Gao, A., Li, P., & Fu, A. (2024). Incidence, characteristics, and risk factors of drug-associated muscle adverse reaction: a retrospective real-world study of inpatients. European Journal of Clinical Pharmacology. https://doi.org/10.1007/s00228-024-03662-0

Vancouver

Zhao A, Guo D, Zhu M, Gao A, Li P, Fu A. Incidence, characteristics, and risk factors of drug-associated muscle adverse reaction: a retrospective real-world study of inpatients. European Journal of Clinical Pharmacology. 2024. doi:10.1007/s00228-024-03662-0

BibTeX
@article{Zhao2024,
  author = {Zhao, Anqi and Guo, Daihong and Zhu, Man and Gao, Ao and Li, Peng and Fu, An},
  title = {Incidence, characteristics, and risk factors of drug-associated muscle adverse reaction: a retrospective real-world study of inpatients},
  journal = {European Journal of Clinical Pharmacology},
  year = {2024},
  doi = {10.1007/s00228-024-03662-0}
}
Kostenlos starten →